Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-07-08
2008-07-08
Tate, Christopher R. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S331000
Reexamination Certificate
active
07396812
ABSTRACT:
A method for modulating Nod1 activity wherein said method comprises the steps of providing cells expressing a functional Nod1; and bringing said cells into contact with a molecule related to compositions comprising a molecule related to MTP and use of a molecule related to MTP for modulating inflammation and/or apoptosis.
REFERENCES:
patent: 2002/0197693 (2002-12-01), Bertin
PCT/IB2004/001318 International Preliminary Report on Patentability, mailed Oct. 13, 2005.
Akira et al., “Toll-like receptors: critical proteins linking innate and acquired immunity”,Nature Immunology, vol. 2, No. 8, pp. 675-680 (2001).
Askew et al., “Molecular Recognition with Convergent Functional Groups. 6. Synthetic and Structural Studies with a Model Receptor for Nucleic Acid Components”,J. Am. Chem. Soc., vol. 111, pp. 1082-1090 (1989).
Bertin et al., “Human CARD4 Protein Is a Novel CED-4/Apaf-1 Cell Death Family Member That Activates NF-κB”,The Journal of Biological Chemistry, vol. 274, No. 19, pp. 12955-12958 (1999).
Blackburn et al., “Identification of Four Families of Peptidoglycan Lytic Transglycosylases”,Journal of Molecular Evolution, vol. 52, pp. 78-84 (2001).
Carballo et al., “Elucidation of the structure of an alanine-lacking core tetrasaccharide trisphosphate from the lipopolysaccharide ofPseudomonas aeruginosamutant H4”,Eur. J. Biochem., vol. 261, pp. 500-508 (1999).
Chin et al., “Involvement of receptor-interacting protein 2 in innate and adaptive immune responses”,Nature, vol. 416, pp. 190-194 (2002).
Choe et al., “Requirement for a Peptidoglycan Recognition Protein (PGRP) in Relish Activation and Antibacterial Immuune Responses inDrosophila”, Science, vol. 296, pp. 359-362 (2002).
De Jonge et al., “Peptidoglycan Composition of a Highly Methicillin-resistantStaphylococcus aureusStrain”,The Journal of Biological Chemistry, vol. 267, No. 16, pp. 11248-11254 (1992).
Eckmann et al., “Analysis by High Density cDNA Arrays of Altered Gene Expression in Human Intestinal Epithelial Cells in Response to Infection with the Invasive Enteric BacteriaSalmonella”, The Journal of Biological Chemistry, vol. 275, No. 19, pp. 14084-14094 (2000).
Girardin et al., “CARD4/NOD1 mediates NF-κB and JNK activation by invasiveShigella flexneri,” EMBO Reports, vol. 2, No. 8, pp. 736-742 (2001).
Girardin et al., “Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection”,The Journal of Biological Chemistry, vol. 278, No. 11, pp. 8869-8872 (2003).
Girardin et al., “Peptidoglycan Molecular Requirements Allowing Detection by Nod1 and Nod2”,The Journal of Biological Chemistry, vol. 278, No. 43, pp. 41702-41708 (2003).
Glauner, “Separation and Quantification of Muropeptides with High-Performance Liquid Chromatography”,Analytical Biochemistry, vol. 172, pp. 451-464 (1988).
Gottar et al., “TheDrosophilaimmune response against Gram-negative bacteria is mediated by a peptidoglycan recognition protein”Nature, vol. 416, pp. 640-644 (2002).
Hayashi et al., “A Rapid Determination of Sodium Dodecyl Sulfate with Methylene Blue”,Analytical Biochemistry, vol. 67, pp. 503-506 (1975).
Hayashi et al., “The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5”,Nature, vol. 410, pp. 1099-1103 (2001).
Höltje et al., “Growth of the Stress-Bearing and Shape-Maintaining Murein Sacculus ofEscherichia coli”, Microbiology and Molecular Biology Reviews, vol. 62, No. 1, pp. 181-203 (1998).
Hugot et al., “Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease”,Nature, vol. 411, pp. 599-603 (2001).
Inohara et al., “An Induced Proximity Model for NF-κB Activation in the Nod1/RICK and RIP Signaling Pathways”,The Journal of Biological Chemistry, vol. 275, No. 36, pp. 27823-27831 (2000).
Inohara et al., “Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2”,The Journal of Biological Chemistry, vol. 278, No. 8, pp. 5509-5512 (2003).
Inohara et al., “Human Nod1 Confers Responsiveness to Bacterial Lipopolysaccharides”,The Journal of Biological Chemistry, vol. 276, No. 4, pp. 2551-2554 (2001).
Inohara et al., “Nod1, an Apaf-1 like Activator of Caspase-9 and Nuclear Factor κB”The Journal of Biological Chemistry, vol. 274, No. 21, pp. 14560-14567 (1999).
Kawai et al., “Unresponsiveness of MyD88-Deficient Mice to Endotoxin”,Immunity, vol. 11, pp. 115-122 (1999).
Kobayashi et al., “RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems”,Nature, vol. 416, pp. 194-199 (2002).
Lee et al., “Two Lipoproteins Extracted fromEscherichia coliK-12 LCD25 Lipopolysaccharide Are the Major Components Responsible for Toll-Like Receptor 2-Mediated Signaling”,The American Association of Immunologies, vol. 168, pp. 4012-4017 (2002).
Lemaitre et al., “The Dorsoventral Regulatory Gene Cassettespätzle/Toll/cactusControls the Potent Antifungal Response in Drosophila Adults”,Cell, vol. 86, pp. 973-983 (1996).
Lewis et al., “Automated site-directed drug design: the concept of spacer skeletons for primary structure generation”Proc. R. Soc. Lond., vol. B236, pp. 125-140 (1989).
Lewis et al., “Automated site-directed drug design: the formation of molecular templates in primary structure generation”,Proc. R. Soc. Lond., vol. B236, pp. 141-162 (1989).
McKinlay et al., “Rational Design of Antiviral Agents”,Ann. Rev. Pharmacol. Toxicol., vol. 29, pp. 111-122 (1989).
McLaughlan et al., “Molecular characterization of an autolytic amidase ofListeriamonocytogenes EGD”,Microbiology, 144, pp. 1359-1367 (1998).
Medzhitov, “Toll-Like Receptors And Innate Immunity”,Nature Immunology, vol. 1, pp. 135-145 (2001).
Michel et al., “DrosophilaToll is activated by Gram-positive bacteria through a circulating peptidoglycan recognition protein”,Nature, vol. 414, pp. 756-759 (2001).
Ogura et al., “A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease”,Nature, vol. 411, pp. 603-606 (2001).
Ogura et al., “Nod2, a Nod1/Apaf-1 Family Member That Is Restricted to Monocytes and Activates NF-κB”,The Journal of Biological Chemistry, vol. 276, No. 7, pp. 4812-4818 (2001).
Pédron et al., “The Invasive Phenotype ofShigella flexneriDirects a Distinct Gene Expression Pattern in the Human Intestinal Epithelial Cell Line Caco-2”,The Journal of Biological Chemistry, vol. 278, No. 36, pp. 33878-33886 (2003).
Perry et al., “The Use of 3D Modelling Databases for Identifying Structure Activity Relationships”,Quantitative Structure-Activity Relationships in Drug Design, pp. 189-193 (1989).
Philpott et al., “InvasiveShigella flexneriActivates NF-κB Through a Lipopolysaccharide-Dependent Innate Intracellular Response and Leads to IL-8 Expression in Epithelial Cells”,The American Association of Immunologists, vol. 165, pp. 903-914 (2000).
Rämet et al., “Functional genomic analysis of phagocytosis and identification of aDrosophilareceptor forE. coli” Nature, vol. 416, pp. 644-648 (2002).
Ripka, “Computers picture the perfect drug”,New Scientist, pp. 54-58 (1988).
Rouvinen et al., “Computer-Aided Drug Design”,Acta Pharmaceutica Fennica, vol. 97, pp. 159-166 (1988).
Uehara et al., “Identification of MpaA, an Amidase inEscherichia coliThat Hydrolyzes the γ-D-Glutamyl-meso-Diaminopimelate Bond in Murein Peptides”,Journal of Bacteriology, vol. 185, No. 2, pp. 679-682 (2003).
Boneca Ivo
Girardin Stephen
Philpott Dana
Sansonetti Philippe
Finnegan Henderson Farabow Garrett & Dunner L.L.P.
Harle Jennifer I
Institut National de la Sante et de la Recherche Medicale
Institut Pasteur
Tate Christopher R.
LandOfFree
Method for modulating Nod1 activity, use of a MTP related... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for modulating Nod1 activity, use of a MTP related..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for modulating Nod1 activity, use of a MTP related... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2793327